Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study

Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer

(2013) D. A. M. Sloothaak et al.   BRITISH JOURNAL OF SURGERY

Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer

(2013) Jung Wook Huh et al.   DISEASES OF THE COLON & RECTUM

Molecular Markers Predict Distant Metastases After Adjuvant Chemoradiation for Rectal Cancer

(2012) Jun Won Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Preoperative Chemoradiation for Rectal Cancer Using Capecitabine and Celecoxib Correlated With Posttreatment Assessment of Thymidylate Synthase and Thymidine Phosphorylase Expression

(2010) Keith R. Unger et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Double blind randomized phase II study with radiation+5-fluorouracil±celecoxib for resectable rectal cancer

(2009) Annelies Debucquoy et al.   RADIOTHERAPY AND ONCOLOGY

Cyclooxygenase-2 Expression Is Related to the Epithelial-to-Mesenchymal Transition in Human Colon Cancers

(2009) Tae Jung Jang et al.   YONSEI MEDICAL JOURNAL

Chemoradiotherapy for Rectal Cancer: An Updated Analysis of Factors Affecting Pathological Response

(2008) P. Sanghera et al.   CLINICAL ONCOLOGY

Preoperative chemoradiationversusradiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis

(2008) Wim Ceelen et al.   INTERNATIONAL JOURNAL OF CANCER

The role of COX-2 in rectal cancer treated with preoperative radiotherapy

(2008) Hanifa Bouzourene et al.   VIRCHOWS ARCHIV